Nigel Dimmock

Affiliations: 
1971- Biological Sciences University of Warwick, Coventry, England, United Kingdom 
Area:
antivirals
Website:
https://warwick.ac.uk/fac/sci/lifesci/people/1/ndimmock/
Google:
"Nigel Dimmock"
Bio:

https://uk.linkedin.com/in/nigel-dimmock-82050923
Research Fellow
Australian National University
1965 – 1970 5 years
Canberra, Australia
Department of Microbiology working on influenza viruses under Frank Fenner, Rob Webster and Graeme Laver

Parents

Sign in to add mentor
Frank Fenner grad student 1965-1970 ANU (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Meng B, Bentley K, Marriott AC, et al. (2017) Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA. Virology Journal. 14: 138
Smith CM, Scott PD, O'Callaghan C, et al. (2016) A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral. Viruses. 8
Marriott AC, Dove BK, Whittaker CJ, et al. (2014) Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. Plos One. 9: e94090
Dimmock NJ, Easton AJ. (2014) Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals? Journal of Virology. 88: 5217-27
Dimmock NJ, Dove BK, Scott PD, et al. (2012) Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. Plos One. 7: e49394
Dimmock NJ, Dove BK, Meng B, et al. (2012) Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Research. 96: 376-85
Scott PD, Meng B, Marriott AC, et al. (2011) Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Vaccine. 29: 6584-91
Scott PD, Meng B, Marriott AC, et al. (2011) Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. The Journal of General Virology. 92: 2122-32
Dimmock NJ, Rainsford EW, Scott PD, et al. (2008) Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. Journal of Virology. 82: 8570-8
Dimmock NJ, Marriott AC. (2006) In vivo antiviral activity: Defective interfering virus protects better against virulent Influenza A virus than avirulent virus Journal of General Virology. 87: 1259-1265
See more...